Kanchi Karpooram growth ratios

Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
−2.4%+19.2%−38.1%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−46.4%+340.5%−76.4%
−56.6%+705.1%−87.4%
−63.8%+882.3%−89.7%
+3.1%+6.7%+1.5%
+2.3%+7.0%+0.4%
−205.6%−66.4%−51.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KANCHI₹378.00

Kanchi Karpooram Limited

· Chemicals
₹ CrorePeersAMALARCLCHEMCRUXDAICHIELANTASGRAUWEILINDOKEMJYOTIRES
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Revenue Growth—-38.1+19.2-2.4
EBITDA Growth—-76.4+340.5-46.4
EBIT Growth—-87.4+705.1-56.6
EPS Growth—-89.7+882.3-63.8
Total Assets Growth—+1.5+6.7+3.1
Total Equity Growth—+0.4+7.0+2.3
Cash from Operations Growth—-51.1-66.4-205.6
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.